Should Older Cancer Patients Receive Priority for Coronavirus Disease 19 Vaccination: Recommendation of the International Geriatric Radiotherapy Group

Article Information

Nam P. Nguyen1*, Vincent Vinh-Hung2, Ulf Karlsson3

1Department of Radiation Oncology, Howard University, Washington, DC, USA

2Department of Radiation Oncology, University of Martinique, Martinique, France,

3Department of Radiation Oncology, International Geriatric Radiotherapy Group, Washington, DC, USA

*Corresponding Author: Nam P. Nguyen, Department of Radiation Oncology, Howard University, Washington, DC, USA

Received: 29 December 2020; Accepted: 12 January 2021; Published: 19 January 2021

Citation: Nam P. Nguyen, Vincent Vinh-Hung, Ulf Karlsson. Should Older Cancer Patients Receive Priority for Coronavirus Disease 19 Vaccination: Recommendation of the International Geriatric Radiotherapy Group. Journal of Surgery and Research 4 (2021): 32-34.

Share at Facebook

Keywords

Coronavirus Disease 19

Coronavirus Disease 19 articles Coronavirus Disease 19 Research articles Coronavirus Disease 19 review articles Coronavirus Disease 19 PubMed articles Coronavirus Disease 19 PubMed Central articles Coronavirus Disease 19 2023 articles Coronavirus Disease 19 2024 articles Coronavirus Disease 19 Scopus articles Coronavirus Disease 19 impact factor journals Coronavirus Disease 19 Scopus journals Coronavirus Disease 19 PubMed journals Coronavirus Disease 19 medical journals Coronavirus Disease 19 free journals Coronavirus Disease 19 best journals Coronavirus Disease 19 top journals Coronavirus Disease 19 free medical journals Coronavirus Disease 19 famous journals Coronavirus Disease 19 Google Scholar indexed journals Cancer Patients articles Cancer Patients Research articles Cancer Patients review articles Cancer Patients PubMed articles Cancer Patients PubMed Central articles Cancer Patients 2023 articles Cancer Patients 2024 articles Cancer Patients Scopus articles Cancer Patients impact factor journals Cancer Patients Scopus journals Cancer Patients PubMed journals Cancer Patients medical journals Cancer Patients free journals Cancer Patients best journals Cancer Patients top journals Cancer Patients free medical journals Cancer Patients famous journals Cancer Patients Google Scholar indexed journals Radiation Oncology articles Radiation Oncology Research articles Radiation Oncology review articles Radiation Oncology PubMed articles Radiation Oncology PubMed Central articles Radiation Oncology 2023 articles Radiation Oncology 2024 articles Radiation Oncology Scopus articles Radiation Oncology impact factor journals Radiation Oncology Scopus journals Radiation Oncology PubMed journals Radiation Oncology medical journals Radiation Oncology free journals Radiation Oncology best journals Radiation Oncology top journals Radiation Oncology free medical journals Radiation Oncology famous journals Radiation Oncology Google Scholar indexed journals Geriatric Radiotherapy articles Geriatric Radiotherapy Research articles Geriatric Radiotherapy review articles Geriatric Radiotherapy PubMed articles Geriatric Radiotherapy PubMed Central articles Geriatric Radiotherapy 2023 articles Geriatric Radiotherapy 2024 articles Geriatric Radiotherapy Scopus articles Geriatric Radiotherapy impact factor journals Geriatric Radiotherapy Scopus journals Geriatric Radiotherapy PubMed journals Geriatric Radiotherapy medical journals Geriatric Radiotherapy free journals Geriatric Radiotherapy best journals Geriatric Radiotherapy top journals Geriatric Radiotherapy free medical journals Geriatric Radiotherapy famous journals Geriatric Radiotherapy Google Scholar indexed journals higher mortality articles higher mortality Research articles higher mortality review articles higher mortality PubMed articles higher mortality PubMed Central articles higher mortality 2023 articles higher mortality 2024 articles higher mortality Scopus articles higher mortality impact factor journals higher mortality Scopus journals higher mortality PubMed journals higher mortality medical journals higher mortality free journals higher mortality best journals higher mortality top journals higher mortality free medical journals higher mortality famous journals higher mortality Google Scholar indexed journals vaccination articles vaccination Research articles vaccination review articles vaccination PubMed articles vaccination PubMed Central articles vaccination 2023 articles vaccination 2024 articles vaccination Scopus articles vaccination impact factor journals vaccination Scopus journals vaccination PubMed journals vaccination medical journals vaccination free journals vaccination best journals vaccination top journals vaccination free medical journals vaccination famous journals vaccination Google Scholar indexed journals vaccine articles vaccine Research articles vaccine review articles vaccine PubMed articles vaccine PubMed Central articles vaccine 2023 articles vaccine 2024 articles vaccine Scopus articles vaccine impact factor journals vaccine Scopus journals vaccine PubMed journals vaccine medical journals vaccine free journals vaccine best journals vaccine top journals vaccine free medical journals vaccine famous journals vaccine Google Scholar indexed journals

Article Details

Across the world, one of the cause for cancer mortality is delay in initiating treatment. A meta-analysis of 34 international studies looking at the impact of treatment delay reported that even a four week delay in surgical, radiotherapy, and systemic treatment lead to poorer outcome in cancer patients [1].

Thus, once cancer diagnosis and proper staging are established, treatment should be initiated as soon as possible. Coronavirus disease 19 (COVID-19) is a pandemic leading to an increase in hospital admissions and potentially overwhelming the availability of intensive care beds for sick patients. As a result, elective surgery or procedures for cancer patients may be cancelled to accommodate for infected patients. An unexpected consequence of the pandemic is the delay in cancer treatment. A survey of 609 cancer breast cancer survivors reported a 54% treatment delay in breast cancer care during the pandemic [2]. Older cancer patients, in particular, face double jeopardy. If infected with the virus, they are likely to have a higher mortality rate compared to younger patients because of the presence of co-morbidity [3]. On the other hand, some country official guidelines advocated against initiating early cancer treatment for infected patients to protect other patients who are immunocompromised from potential contagion [4].

Thus, physicians face an ethical dilemma. Delaying treatment of older and infected cancer patients which constitute a minority of the cancer population may be necessary to protect other cancer patients. This difficult challenge may be avoided if older cancer patients are prevented from getting the infection which allow them to receive treatment without delay and protect them at the same time from the virus.

The recent approval of the COVID-19 Pfizer vaccine and the Moderna vaccine provides a potential solution for those patients [5]. The vaccine is safe and effective for older patients. A 95% protection rate against COVID-19 was reported for all patients older than 16 years of age [5]. Given the limited availability of the vaccine, health care workers have received priority for the vaccination. Nursing home patients are also on the priority list because of their higher mortality. Who should be next on the list?

As an international organization devoted to the care of older cancer patients who are frequently excluded from clinical trials because of their chronological age (http://www.igrg.org), we advocate that older cancer patients should receive priority for COVID-19 vaccination [6]. They could be enrolled into a clinical trial as soon as possible after vaccination [7]. The vaccine not only improves the quality of their care but also protects other cancer patients from being infected, thus fulfilling the guidelines for cancer patients protection during the pandemic.

References

  1. Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systemic review and meta-analysis. BMJ 371 (2020): m4087.
  2. Papautsky EL, Hamlish T. Patient reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treatment 184 (2020): 249-254.
  3. Lee LYW, Caziez JB, Starkey T, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumor subtype and patient demographics: a prospective cohort study. Lancet Oncol 10 (3020): 1309-1316.
  4. You B, Ravaud A, Canivet A, et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol 21 (2020): 619-621.
  5. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID vaccine. N Engl J Med 2020.
  6. Tiberiu P, Karlsson U, Vinh-Hung V, et al. Challenges facing radiation oncologists in the management of older cancer patients: consensus of the International Geriatric Radiotherapy Group. Cancers 11 (2019): 371.
  7. Nguyen NP, Vinh-Hung V, Baumert B, et al. Older cancer patients during the COVID-19 epidemic: practice proposal of the International Geriatric Radiotherapy Group. Cancers 20 (2020):1287.

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved